Cas no 99847-17-3 (4-(3-Nitrophenoxy)-benzoic acid)
4-(3-Nitrophenoxy)-benzoic acid Chemical and Physical Properties
Names and Identifiers
-
- 4-(3-Nitrophenoxy)-benzoic acid
- 4-(3-nitrophenoxy)Benzoic acid
-
- MDL: MFCD08097470
- Inchi: 1S/C13H9NO5/c15-13(16)9-4-6-11(7-5-9)19-12-3-1-2-10(8-12)14(17)18/h1-8H,(H,15,16)
- InChI Key: AEMXUPRNANAQQS-UHFFFAOYSA-N
- SMILES: O(C1C=CC=C(C=1)[N+](=O)[O-])C1C=CC(C(=O)O)=CC=1
Computed Properties
- Hydrogen Bond Donor Count: 1
- Hydrogen Bond Acceptor Count: 3
- Heavy Atom Count: 19
- Rotatable Bond Count: 4
4-(3-Nitrophenoxy)-benzoic acid Pricemore >>
| Related Categories | No. | Product Name | Cas No. | Purity | Specification | Price | update time | Inquiry |
|---|---|---|---|---|---|---|---|---|
| abcr | AB451037-250 mg |
4-(3-Nitrophenoxy)benzoic acid; . |
99847-17-3 | 250MG |
€246.20 | 2023-07-18 | ||
| abcr | AB451037-1 g |
4-(3-Nitrophenoxy)benzoic acid; . |
99847-17-3 | 1g |
€538.80 | 2023-07-18 | ||
| eNovation Chemicals LLC | Y1256722-250mg |
Benzoic acid, 4-(3-nitrophenoxy)- |
99847-17-3 | 95% | 250mg |
$165 | 2024-06-06 | |
| eNovation Chemicals LLC | Y1256722-1g |
Benzoic acid, 4-(3-nitrophenoxy)- |
99847-17-3 | 95% | 1g |
$260 | 2024-06-06 | |
| eNovation Chemicals LLC | Y1256722-5g |
Benzoic acid, 4-(3-nitrophenoxy)- |
99847-17-3 | 95% | 5g |
$775 | 2024-06-06 | |
| eNovation Chemicals LLC | Y1256722-250mg |
Benzoic acid, 4-(3-nitrophenoxy)- |
99847-17-3 | 95% | 250mg |
$165 | 2025-02-19 | |
| eNovation Chemicals LLC | Y1256722-1g |
Benzoic acid, 4-(3-nitrophenoxy)- |
99847-17-3 | 95% | 1g |
$260 | 2025-02-19 | |
| eNovation Chemicals LLC | Y1256722-5g |
Benzoic acid, 4-(3-nitrophenoxy)- |
99847-17-3 | 95% | 5g |
$775 | 2025-02-19 | |
| abcr | AB451037-250mg |
4-(3-Nitrophenoxy)benzoic acid; . |
99847-17-3 | 250mg |
€249.40 | 2025-04-14 | ||
| abcr | AB451037-1g |
4-(3-Nitrophenoxy)benzoic acid; . |
99847-17-3 | 1g |
€546.70 | 2025-04-14 |
4-(3-Nitrophenoxy)-benzoic acid Related Literature
-
Jialiang Yuan,Ran Dong,Yuan Li,Yang Liu,Zhuo Zheng,Yuxia Liu,Yan Sun,Benhe Zhong,Zhenguo Wu,Xiaodong Guo Chem. Commun., 2021,57, 13004-13007
-
Kanjun Sun,Fengting Hua,Shuzhen Cui,Yanrong Zhu,Hui Peng,Guofu Ma RSC Adv., 2021,11, 37631-37642
-
Chongyang Zhu,Xiaojia Bian,Xin Jia,Ning Tang,Yongqiang Cheng Food Funct., 2020,11, 10635-10644
-
Supaporn Sawadjoon,Joseph S. M. Samec Org. Biomol. Chem., 2011,9, 2548-2554
Additional information on 4-(3-Nitrophenoxy)-benzoic acid
Recent Advances in the Study of 4-(3-Nitrophenoxy)-benzoic acid (CAS: 99847-17-3)
4-(3-Nitrophenoxy)-benzoic acid (CAS: 99847-17-3) is a chemical compound that has garnered significant attention in the field of chemical biology and pharmaceutical research due to its potential applications in drug development and therapeutic interventions. Recent studies have focused on elucidating its molecular mechanisms, synthetic pathways, and biological activities, providing valuable insights for future research and clinical applications.
One of the key areas of investigation has been the compound's role as an intermediate in the synthesis of more complex pharmaceutical agents. Researchers have optimized synthetic routes to produce 4-(3-Nitrophenoxy)-benzoic acid with high yield and purity, which is critical for its subsequent use in drug development. Advanced spectroscopic techniques, including NMR and mass spectrometry, have been employed to characterize the compound and confirm its structural integrity.
In addition to its synthetic utility, 4-(3-Nitrophenoxy)-benzoic acid has been studied for its potential biological activities. Preliminary in vitro studies suggest that the compound may exhibit anti-inflammatory and antioxidant properties, making it a candidate for further investigation in the treatment of chronic inflammatory diseases. Molecular docking studies have also indicated potential interactions with key enzymes involved in inflammatory pathways, although further validation is required.
Another promising avenue of research involves the modification of 4-(3-Nitrophenoxy)-benzoic acid to enhance its pharmacological properties. Recent work has explored the introduction of various functional groups to improve its solubility, bioavailability, and target specificity. These modifications could pave the way for the development of novel therapeutics with improved efficacy and reduced side effects.
Despite these advancements, challenges remain in the clinical translation of 4-(3-Nitrophenoxy)-benzoic acid. Issues such as stability under physiological conditions, potential toxicity, and pharmacokinetic profiles need to be addressed through comprehensive preclinical studies. Collaborative efforts between chemists, biologists, and pharmacologists will be essential to overcome these hurdles and unlock the full potential of this compound.
In conclusion, 4-(3-Nitrophenoxy)-benzoic acid (CAS: 99847-17-3) represents a promising candidate for further research in the chemical biology and pharmaceutical fields. Its versatile applications, from synthetic intermediate to potential therapeutic agent, highlight its importance in ongoing scientific endeavors. Future studies should focus on optimizing its properties and evaluating its safety and efficacy in relevant biological models.
99847-17-3 (4-(3-Nitrophenoxy)-benzoic acid) Related Products
- 78238-12-7(3-Methoxy-5-nitrobenzoic acid)
- 2597-56-0(2-Methoxy-4-nitrobenzoic acid)
- 16309-45-8(4-(4-Nitrophenoxy)benzoic acid)
- 87740-04-3(Benzoic acid, 4-[(3-nitrophenoxy)methyl]-)
- 88086-70-8(Benzoic acid, 2-(4-methylphenoxy)-4-nitro-)
- 87740-05-4(4-(4-nitrophenoxy)methylbenzoic acid)
- 6312-86-3(Benzoic acid,2-(3-nitrophenoxy)-)
- 77769-87-0(Benzoic acid, 2-(4-carboxyphenoxy)-4-nitro-)
- 62290-39-5(Benzoic acid, 4-[(4-nitrophenyl)methoxy]-)
- 103440-97-7(Benzoic acid,3-ethoxy-5-nitro-)